CACNA1A Gene
Introduction
CACNA1A (Calcium Voltage-Gated Channel Subunit Alpha1 A) encodes the alpha-1A subunit of voltage-gated P/Q-type calcium channels (CaV2.1), one of the most important voltage-gated calcium channels in the central nervous system. These channels are critical for neurotransmitter release at presynaptic terminals, particularly in cerebellar Purkinje cells and hippocampal neurons. Mutations in CACNA1A cause a spectrum of neurological disorders including spinocerebellar ataxias, familial hemiplegic migraine, episodic ataxia, and epilepsy [@pietrobon2010].
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#2c5282; color:white; text-align:center;">CACNA1A Gene Information</th></tr>
<tr><td><strong>Symbol</strong></td><td>CACNA1A</td></tr>
<tr><td><strong>Full Name</strong></td><td>Calcium Voltage-Gated Channel Subunit Alpha1 A</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19p13.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[773](https://www.ncbi.nlm.nih.gov/gene/773)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[601011](https://www.omim.org/entry/601011)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>[ENSG00000141837](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141837)</td></tr>
<tr><td><strong>UniProt</strong></td><td>[O00555](https://www.uniprot.org/uniprot/O00555)</td></tr>
<tr><td><strong>Protein</strong></td><td>[CaV2.1 (P/Q-type calcium channel)](/proteins/cav2.1-)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[SCA2](/diseases/spinocerebellar-ataxia-type-2), [FHM](/diseases/familial-hemiplegic-migraine), [Epilepsy](/diseases/epilepsy), [Developmental Ataxia](/diseases/developmental-ataxia)</td></tr>
</table>
</div>
Overview
The CACNA1A gene is essential for normal neurological function. It encodes the pore-forming alpha-1A subunit of P/Q-type calcium channels, which are high-voltage-activated channels that conduct calcium ions essential for synaptic transmission. The channel consists of multiple subunits:
- Alpha-1A subunit: The pore-forming subunit encoded by CACNA1A
- Alpha-2/delta subunit: Auxiliary subunit that modulates channel trafficking and function
- Beta subunit: Auxiliary subunit that regulates channel kinetics
- Gamma subunit: Auxiliary subunit that influences channel properties
P/Q-type channels are the predominant calcium channel type at cerebellar synapses, where they mediate fast synaptic transmission and are critical for proper motor coordination [@graves2024].
Function
Normal Physiological Function
CACNA1A-encoded CaV2.1 channels play several critical roles in the nervous system:
Synaptic Transmission: P/Q-type channels are the primary voltage-gated calcium channels at presynaptic terminals, triggering neurotransmitter release through their high-affinity calcium binding [@mintz1992].
Cerebellar Function: CaV2.1 channels are essential for proper cerebellar Purkinje cell function, which integrates motor learning signals and coordinates movement.
Hippocampal Signaling: In the hippocampus, P/Q-type channels contribute to synaptic plasticity, learning, and memory processes.
Neuromuscular Junction: At the motor nerve terminal, P/Q-type channels mediate acetylcholine release for muscle contraction.
Gene Regulation: Through calcium-dependent signaling cascades, these channels regulate transcription factors and gene expression programs important for neuronal survival.Channel Structure and Gating
The CaV2.1 channel has complex gating properties:
- Activation: Voltage-dependent opening at membrane potentials around -40 mV
- Inactivation: Both voltage-dependent and calcium-dependent inactivation
- Conductance: High single-channel conductance (~15 pS)
- Dihydropyridine sensitivity: Differs from L-type channels
Expression Pattern
CaV2.1 channels are expressed in a cell-type specific manner:
| Brain Region | Expression Level | Primary Cell Types |
|--------------|------------------|-------------------|
| Cerebellum | Very High | Purkinje cells, Granule cells |
| Hippocampus | High | CA3 pyramidal cells, Interneurons |
| Cerebral Cortex | High | Layer 5 pyramidal neurons |
| Thalamus | High | Relay neurons |
| Dorsal Root Ganglia | Moderate | Sensory neurons |
| Brainstem | Moderate | Various neuron types |
The high expression in cerebellar Purkinje cells explains the ataxia phenotypes observed in CACNA1A mutations [@cunha2023].
Role in Neurodegenerative Diseases
Alzheimer's Disease
Emerging evidence links CACNA1A to Alzheimer's disease pathogenesis:
- Calcium Dysregulation: AD brains show altered P/Q-type channel expression and function, contributing to the calcium dysregulation hypothesis of AD [@du2015].
- Synaptic Loss: CaV2.1 dysfunction contributes to impaired synaptic transmission in AD.
- Excitotoxicity: Dysregulated calcium influx through mutant channels may contribute to excitotoxic neuronal death.
- Amyloid Interaction: Amyloid-beta oligomers can directly affect P/Q-type channel function in hippocampal neurons [@chen2020].
| AD Association | Mechanism |
|----------------|-----------|
| Calcium dysregulation | Altered channel expression/function |
| Synaptic impairment | Reduced neurotransmitter release |
| Excitotoxicity | Abnormal calcium influx |
| Memory deficits | Hippocampal dysfunction |
Parkinson's Disease
While less studied than in AD, CACNA1A may play roles in PD:
- Nigral Expression: P/Q-type channels are expressed in dopaminergic neurons of the substantia nigra.
- Calcium-dependent Vulnerability: The unique calcium dynamics of dopaminergic neurons may be affected by CACNA1A variants.
- Therapeutic Implications: P/Q-type channel modulators are being explored as potential neuroprotective agents.
Spinocerebellar Ataxia Type 2 (SCA2)
CACNA1A mutations cause SCA2, one of the most common autosomal dominant ataxias:
- Pathogenic Mechanisms: Polyglutamine expansions and point mutations lead to channel dysfunction.
- Phenotype: Progressive ataxia, dysarthria, peripheral neuropathy, and slow saccades.
- Therapeutic Approaches: Gene therapy and small molecule correctors under investigation.
Other Neurological Disorders
| Disorder | CACNA1A Role |
|----------|-------------|
| Familial Hemiplegic Migraine (FHM) | Gain-of-function mutations cause aura and hemiparesis |
| Episodic Ataxia Type 2 (EA2) | Loss-of-function mutations cause episodic ataxia and nystagmus |
| Epilepsy | Various mutations cause neuronal hyperexcitability |
| Developmental Ataxia | Developmental delays with ataxic features |
Molecular Mechanisms
Calcium-Dependent Signaling
Mermaid diagram (expand to render)
Channel Dysfunction Mechanisms
Loss-of-function: Reduced channel activity leads to decreased neurotransmitter release
Gain-of-function: Increased channel activity causes calcium overload and excitotoxicity
Dominant-negative: Mutant subunits incorporate into channels and impair function
Trafficking defects: Mutations affect channel localization to the membraneTherapeutic Approaches
Current Treatments
- Acetazolamide: Carbonic anhydrase inhibitor used for episodic ataxia
- Flunarizine: Calcium channel blocker for migraine prophylaxis
- Topiramate: Anti-convulsant with calcium channel effects
- Valproic Acid: Mood stabilizer with calcium channel modulatory effects
Emerging Therapies
| Approach | Status | Target |
|----------|--------|--------|
| Gene therapy | Preclinical | Restore channel function |
| Small molecule correctors | Discovery | Improve channel trafficking |
| Antisense oligonucleotides | Research | Reduce toxic protein expression |
| Calcium channel blockers | Clinical trials | Reduce excitotoxicity |
Genetics and Inheritance
Mutation Types
- Missense mutations: Alter channel gating or conductance
- Nonsense/frameshift: Cause haploinsufficiency
- SCA2 expansions: CAG repeat expansions causing polyglutamine toxicity
- Splice site mutations: Altered channel isoform expression
Inheritance Patterns
- Autosomal dominant: Most SCA2, FHM, and EA2 mutations
- De novo: Many developmental ataxia cases
- Variable penetrance: Phenotype depends on specific mutation
Key Historical Discoveries
1991: First cloning of CACNA1A cDNA [@mori1991]
1996: Identification of FHM and EA2 mutations [@ophoff1996]
2000s: Link to SCA2 pathogenesis established
2010s: CaV2.1 channel structure resolved
2020s: Gene therapy approaches enter development [@hommersom2025]Animal Models
- Tottering mouse: Natural CACNA1A mutant with ataxia and seizures
- Rolling mouse: Another natural mutant with Purkinje cell degeneration
- Knockout mice: Complete loss of CaV2.1 function
- Transgenic models: Expressing human mutations for therapeutic testing
See Also
- [CaV2.1 Protein](/proteins/cav2.1-)
- [Voltage-Gated Calcium Channels](/proteins/voltage-gated-calcium-channels)
- [Spinocerebellar Ataxia](/diseases/spinocerebellar-ataxia-type-2)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Ion Channel Genes](/entities/ion-channel-genes)
- [Synaptic Transmission](/mechanisms/synaptic-transmission)
References
[Villar-Martinez MD, Moreno-Ajona D, Goadsby PJ, "Familial hemiplegic migraine." Handbook of clinical neurology (2024)](https://doi.org/10.1016/B978-0-323-90820-7.00007-0)
[Graves TD et al., "The episodic ataxias." Handbook of clinical neurology (2024)](https://doi.org/10.1016/B978-0-323-90820-7.00012-4)
[Coutelier M et al., "Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes." JAMA neurology (2018)](https://pubmed.ncbi.nlm.nih.gov/29482223/)
[Jen JC, Wan J, "Episodic ataxias." Handbook of clinical neurology (2018)](https://doi.org/10.1016/B978-0-444-64189-2.00013-5)
[Pietrobon D, "CaV2.1 channelopathies." Pflugers Archiv : European journal of physiology (2010)](https://pubmed.ncbi.nlm.nih.gov/20204399/)
[Hommersom MP et al., "CACNA1A haploinsufficiency leads to reduced synaptic function and increased intrinsic excitability." Brain : a journal of neurology (2025)](https://doi.org/10.1093/brain/awae330)
[El Ghaleb Y et al., "CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders." Brain : a journal of neurology (2021)](https://doi.org/10.1093/brain/awab101)
[Cunha P et al., "Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias." American journal of human genetics (2023)](https://pubmed.ncbi.nlm.nih.gov/37301203/)
[Mori Y et al., "Primary structure and functional expression from complementary DNA of the brain calcium channel." Nature (1991)](https://pubmed.ncbi.nlm.nih.gov/1842122/)
[Ophoff RA et al., "Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4." Cell (1996)](https://pubmed.ncbi.nlm.nih.gov/8617203/)
[Mintz IM et al., "P-type calcium channels in rat central and peripheral neurons." Neuron (1992)](https://pubmed.ncbi.nlm.nih.gov/1314507/)
[Du X et al., "Calcium channel dysfunction in the entorhinal cortex in Alzheimer disease." Neurobiology of Aging (2015)](https://pubmed.ncbi.nlm.nih.gov/26165922/)
[Chen X et al., "P/Q-type calcium channel dysfunction in primary cortical neurons from the 5xFAD mouse model of Alzheimer disease." Acta Neuropathologica Communications (2020)](https://pubmed.ncbi.nlm.nih.gov/32234095/)
[Stahl T et al., "Mutant CACNA1A spinocerebellar ataxia type 6 models exhibit modified alpha1A subunit processing and restricted phenotypes in neurons and photoreceptors." Brain Research (2020)](https://pubmed.ncbi.nlm.nih.gov/31887304/)
[Schubert J et al., "De novo missense mutations in CACNA1A: a novel mechanism for hemiplegic migraine?" Cephalalgia (2022)](https://pubmed.ncbi.nlm.nih.gov/34859317/)Additional Reading
The CACNA1A gene represents a fascinating case study in how ion channel dysfunction can lead to diverse neurological phenotypes. From the initial discovery of its role in familial hemiplegic migraine to the identification of its involvement in spinocerebellar ataxias, research has revealed the critical importance of P/Q-type calcium channels in neuronal function.
Clinical Perspectives
Patients with CACNA1A mutations present with a wide spectrum of symptoms, reflecting the diverse roles of CaV2.1 channels in different brain regions. Cerebellar involvement manifests as ataxia and coordination difficulties, while cortical and hippocampal involvement can lead to cognitive impairments and epilepsy. The variability in phenotype makes diagnosis challenging and underscores the need for genetic testing in suspected cases.
Research Directions
Current research focuses on understanding the precise mechanisms by which different CACNA1A mutations lead to distinct phenotypes. Studies are investigating:
- How specific mutations affect channel trafficking and function
- The role of auxiliary subunits in modifying disease severity
- Potential therapeutic targets for preventing neuronal dysfunction
- Gene therapy approaches to restore proper channel function
CACNA1A interacts with numerous other proteins and signaling pathways:
- Synaptic vesicle proteins involved in neurotransmitter release
- Calcium-dependent kinases and phosphatases
- Proteins involved in channel trafficking and anchoring
- Transcription factors regulated by calcium signaling